Dominique Sanglard

24.1k total citations · 5 hit papers
227 papers, 18.5k citations indexed

About

Dominique Sanglard is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Dominique Sanglard has authored 227 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Infectious Diseases, 125 papers in Epidemiology and 61 papers in Molecular Biology. Recurrent topics in Dominique Sanglard's work include Antifungal resistance and susceptibility (166 papers), Fungal Infections and Studies (85 papers) and Pneumocystis jirovecii pneumonia detection and treatment (67 papers). Dominique Sanglard is often cited by papers focused on Antifungal resistance and susceptibility (166 papers), Fungal Infections and Studies (85 papers) and Pneumocystis jirovecii pneumonia detection and treatment (67 papers). Dominique Sanglard collaborates with scholars based in Switzerland, United States and United Kingdom. Dominique Sanglard's co-authors include Jacques Billé, Françoise Ischer, Michel Monod, Alix T. Coste, Frank C. Odds, Sarah J. Gurr, Nichola J. Hawkins, Matthew C. Fisher, Bernhard Hube and David Calabrese and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Dominique Sanglard

226 papers receiving 18.0k citations

Hit Papers

Worldwide emergence ... 1995 2026 2005 2015 2018 1995 2002 2014 2016 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Worldwide emergence of resistance to antifungal drugs challenges human health and food security
    2018 1.1k citations Dominique Sanglard et al. profile →
  2. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
    1995 667 citations Dominique Sanglard, Karl Kuchler et al. Antimicrobial Agents and Chemotherapy profile →
  3. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
    2002 616 citations Dominique Sanglard et al. profile →
  4. Mechanisms of Antifungal Drug Resistance
    2014 448 citations Dominique Sanglard et al. profile →
  5. Emerging Threats in Antifungal-Resistant Fungal Pathogens
    2016 321 citations Dominique Sanglard profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominique Sanglard Switzerland 72 12.6k 9.2k 5.0k 3.0k 2.0k 227 18.5k
David S. Perlin United States 77 13.3k 1.1× 10.5k 1.1× 4.1k 0.8× 2.7k 0.9× 1.1k 0.6× 301 18.8k
Frank C. Odds United Kingdom 79 15.5k 1.2× 11.0k 1.2× 5.4k 1.1× 2.7k 0.9× 1.4k 0.7× 265 21.3k
Bernhard Hube Germany 83 14.9k 1.2× 10.3k 1.1× 6.2k 1.2× 2.1k 0.7× 2.4k 1.2× 301 21.3k
Theodore C. White United States 50 7.6k 0.6× 6.4k 0.7× 3.7k 0.7× 3.1k 1.0× 826 0.4× 115 13.8k
José L. López-Ribot United States 70 11.1k 0.9× 6.2k 0.7× 5.4k 1.1× 1.4k 0.5× 732 0.4× 194 15.9k
Scott G. Filler United States 70 13.6k 1.1× 9.6k 1.0× 4.1k 0.8× 1.5k 0.5× 1.3k 0.7× 229 18.1k
Alistair J. P. Brown United Kingdom 74 10.3k 0.8× 6.8k 0.7× 8.3k 1.7× 3.0k 1.0× 1.1k 0.6× 251 17.2k
Cornelia Lass‐Flörl Austria 67 14.1k 1.1× 11.0k 1.2× 1.9k 0.4× 1.8k 0.6× 1.1k 0.6× 466 18.8k
Michel Monod Switzerland 62 6.0k 0.5× 6.7k 0.7× 3.4k 0.7× 2.3k 0.8× 1.6k 0.8× 217 12.9k
John R. Perfect United States 101 24.1k 1.9× 24.1k 2.6× 5.7k 1.1× 5.3k 1.8× 2.2k 1.1× 439 34.1k

Countries citing papers authored by Dominique Sanglard

Since Specialization
Citations

This map shows the geographic impact of Dominique Sanglard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Sanglard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Sanglard more than expected).

Fields of papers citing papers by Dominique Sanglard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Sanglard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Sanglard. The network helps show where Dominique Sanglard may publish in the future.

Co-authorship network of co-authors of Dominique Sanglard

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Sanglard. A scholar is included among the top collaborators of Dominique Sanglard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Sanglard. Dominique Sanglard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coste, Alix T., et al.. (2024). Upc2-mediated mechanisms of azole resistance in Candida auris. Microbiology Spectrum. 12(2). e0352623–e0352623. 17 indexed citations
2.
Ivanov, Marija, Abhilash Kannan, Dejan Stojković, et al.. (2021). Camphor and Eucalyptol—Anticandidal Spectrum, Antivirulence Effect, Efflux Pumps Interference and Cytotoxicity. International Journal of Molecular Sciences. 22(2). 483–483. 59 indexed citations
3.
Ivanov, Marija, Abhilash Kannan, Dejan Stojković, et al.. (2020). Flavones, Flavonols, and Glycosylated Derivatives—Impact on Candida albicans Growth and Virulence, Expression of CDR1 and ERG11, Cytotoxicity. Pharmaceuticals. 14(1). 27–27. 56 indexed citations
4.
Kannan, Abhilash, et al.. (2019). Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae. mBio. 10(6). 45 indexed citations
5.
Tran, Van Du T., et al.. (2018). Condition-specific series of metabolic sub-networks and its application for gene set enrichment analysis. Bioinformatics. 35(13). 2258–2266. 12 indexed citations
6.
Astvad, Karen Marie Thyssen, et al.. (2018). Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models. Antimicrobial Agents and Chemotherapy. 62(12). 30 indexed citations
7.
Vale-Silva, Luís A., Emmanuel Beaudoing, Van Du T. Tran, & Dominique Sanglard. (2017). Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates. G3 Genes Genomes Genetics. 7(8). 2413–2426. 48 indexed citations
8.
Filipuzzi, Ireos, Simona Cotesta, Francesca Perruccio, et al.. (2016). High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines. PLoS Genetics. 12(11). e1006374–e1006374. 21 indexed citations
9.
Vale-Silva, Luís A. & Dominique Sanglard. (2015). Tipping the balance both ways: drug resistance and virulence in Candida glabrata. FEMS Yeast Research. 15(4). fov025–fov025. 55 indexed citations
10.
Hare, Rasmus Krøger, Karen Marie Thyssen Astvad, Dominique Sanglard, et al.. (2015). Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistancein vivoinCandida albicansorchestrated by multiple genetic alterations. Journal of Antimicrobial Chemotherapy. 70(9). 2551–2555. 66 indexed citations
11.
Alcázar‐Fuoli, Laura, Isabel Cuesta, Juan L. Rodrı́guez-Tudela, et al.. (2011). Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction. International Journal of Antimicrobial Agents. 38(5). 426–434. 20 indexed citations
12.
Vandeputte, Patrick, Françoise Ischer, Dominique Sanglard, & Alix T. Coste. (2011). In Vivo Systematic Analysis of Candida albicans Zn2-Cys6 Transcription Factors Mutants for Mice Organ Colonization. PLoS ONE. 6(10). e26962–e26962. 45 indexed citations
13.
Torelli, Riccardo, Brunella Posteraro, Sélène Ferrari, et al.. (2008). The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata. Molecular Microbiology. 68(1). 186–201. 113 indexed citations
14.
Sanglard, Dominique, et al.. (2006). Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans. Antimicrobial Agents and Chemotherapy. 50(4). 1365–1371. 69 indexed citations
15.
Pardini, Giacomo, et al.. (2006). CRZ1 , a target of the calcineurin pathway in Candida albicans. Molecular Microbiology. 59(5). 1429–1451. 186 indexed citations
16.
Helmerhorst, Eva J., et al.. (2006). Roles of Cellular Respiration, Cg CDR1 , and Cg CDR2 in Candida glabrata Resistance to Histatin 5. Antimicrobial Agents and Chemotherapy. 50(3). 1100–1103. 18 indexed citations
17.
Felk, Angelika, Marianne Kretschmar, Antje Albrecht, et al.. (2002). Candida albicans Hyphal Formation and the Expression of the Efg1-Regulated Proteinases Sap4 to Sap6 Are Required for the Invasion of Parenchymal Organs. Infection and Immunity. 70(7). 3689–3700. 214 indexed citations
18.
Sanglard, Dominique, et al.. (1998). Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. Drug Resistance Updates. 1(4). 255–265. 81 indexed citations
19.
Egner, Ralf, et al.. (1998). Genetic Separation of FK506 Susceptibility and Drug Transport in the Yeast Pdr5 ATP-binding Cassette Multidrug Resistance Transporter. Molecular Biology of the Cell. 9(2). 523–543. 123 indexed citations
20.
Sanglard, Dominique. (1992). Disruption of the gene encoding the secreted acid protease (ACP) in the yeast Candida tropicalis. FEMS Microbiology Letters. 95(2-3). 149–156. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David S. Perlin Breakdown of academic impact, for papers by Frank C. Odds Breakdown of academic impact, for papers by Bernhard Hube Breakdown of academic impact, for papers by Theodore C. White Breakdown of academic impact, for papers by José L. López-Ribot Breakdown of academic impact, for papers by Scott G. Filler Breakdown of academic impact, for papers by Alistair J. P. Brown Breakdown of academic impact, for papers by Cornelia Lass‐Flörl Breakdown of academic impact, for papers by Michel Monod Breakdown of academic impact, for papers by John R. Perfect
Rankless by CCL
2026